Effect of calcium channel blocker in combination with an angiotensin II receptor blocker in Japanese patients with hypertension

被引：0
|
作者：
Saruta, Takao [1 ]
机构：
[1] Keio Univ, Tokyo 108, Japan
来源：
DRUGS | 2006年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
It is hard to achieve antihypertensive goal in daily clinical practice. Combination therapy is mostly applied since antihypertensive therapy with single agent has limitations. Ca channel blocker (CCB), angiotension II receptor blocker (ARB) and angiotensin-converting enzyme (ACE) inhibitor are current mainstream antiltypertensives and combination therapy of CCB and ARB is especially applied. CCB shows good antihypertensive effect and has fewer side-effects. On the other hand, ARB inhibits renin-angiotensin system and excels at cardioprotective and renoprotective effect. These combination therapies are vital to achieve antihypertensive goal. In the years ahead, it is necessary to review whether or not there are differences on the effect and medical cost economy even between antihypertensive agents in the same class.
引用
收藏
页码：19 / 21
页数：3
相关论文
共 50 条
  • [1] Effect of an angiotensin II receptor blocker and a calcium channel blocker on hypertension associated penile dysfunction in a rat model
    Shimizu, Shogo
    Tsounapi, Panagiota
    Honda, Masashi
    Dimitriadis, Fotios
    Taniuchi, Keisuke
    Shimizu, Takahiro
    Inoue, Keiji
    Saito, Motoaki
    BIOMEDICAL RESEARCH-TOKYO, 2014, 35 (03): : 215 - 221
  • [2] Renoprotective effect of a calcium channel blocker, benidipine, in combination with an angiotensin II receptor blocker in hypertensive patients with chronic kidney disease
    Dohi, Y.
    Miyagawa, K.
    Nakazawa, A.
    Kimura, G.
    JOURNAL OF HYPERTENSION, 2008, 26 : S515 - S515
  • [3] Combination Therapy of Calcium Channel Blocker and Angiotensin II Receptor Blocker Reduces Augmentation Index in Hypertensive Patients
    Doi, Masayuki
    Miyoshi, Toru
    Hirohata, Satoshi
    Kamikawa, Shigeshi
    Usui, Shinichi
    Kaji, Youko
    Sakane, Kosuke
    Ogawa, Hiroko
    Ninomiya, Yoshifumi
    Kusachi, Shozo
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2010, 339 (05): : 433 - 439
  • [4] Comparison of the Effect of Combination Therapy with an Angiotensin II Receptor Blocker and Either a Low-Dose Diuretic or Calcium Channel Blocker on Cardiac Hypertrophy in Patients with Hypertension
    Okura, Takafumi
    Miyoshi, Ken-ichi
    Irita, Jun
    Enomoto, Daijiro
    Jotoku, Masanori
    Nagao, Tomoaki
    Watanabe, Kouki
    Matsuoka, Hiroshi
    Ashihara, Toshiaki
    Higaki, Jitsuo
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2013, 35 (08) : 563 - 569
  • [5] Dose Timing of an Angiotensin II Receptor Blocker/Calcium Channel Blocker Combination in Hypertensive Patients With Paroxysmal Atrial Fibrillation
    Kario, Kazuomi
    Hoshide, Satoshi
    Uchiyama, Kazuaki
    Yoshida, Tetsuro
    Okazaki, Osamu
    Noshiro, Takao
    Aoki, Hirotaka
    Mizuno, Hiroyuki
    Matsumoto, Yuri
    JOURNAL OF CLINICAL HYPERTENSION, 2016, 18 (10): : 1036 - 1044
  • [6] The Role of Angiotensin Receptor Blocker and Calcium Channel Blocker Combination Therapy in Treating Hypertension Focus on Recent Studies
    Chrysant, Steven G.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2010, 10 (05) : 315 - 320
  • [7] Effects of Exercise Therapy Alone and in Combination with a Calcium Channel Blocker or an Angiotensin Receptor Blocker in Hypertensive Patients
    Ohta, Masanori
    Tajiri, Yuji
    Yamato, Hiroshi
    Ikeda, Masaharu
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2012, 34 (07) : 523 - 529
  • [8] Beneficial Effect of Combination Therapy Comprising Angiotensin II Receptor Blocker Plus Calcium Channel Blocker on Plasma Adiponectin Levels
    Inoue, Yukiko
    Kakuma, Tatsuyuki
    Nonaka, Yoshisuke
    Sumi, Shunichiro
    Okamura, Keisuke
    Kodama, Sunao
    Ando, Chie
    Niimura, Hideya
    Miyoshi, Kei
    Tsuchiya, Yoshihiro
    Yamanouchi, Yoshio
    Urata, Hidenori
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2010, 32 (01) : 21 - 28
  • [9] Comparison of combination therapies, including the angiotensin receptor blocker olmesartan and either a calcium channel blocker or a thiazide diuretic, in elderly patients with hypertension
    Kato, Johji
    Yokota, Naoto
    Tamaki, Noboru
    Kariya, Sumito
    Kita, Toshihiro
    Ayabe, Takao
    Eto, Tanenao
    Kitamura, Kazuo
    HYPERTENSION RESEARCH, 2011, 34 (03) : 331 - 335
  • [10] Comparison of combination therapies, including the angiotensin receptor blocker olmesartan and either a calcium channel blocker or a thiazide diuretic, in elderly patients with hypertension
    Johji Kato
    Naoto Yokota
    Noboru Tamaki
    Sumito Kariya
    Toshihiro Kita
    Takao Ayabe
    Tanenao Eto
    Kazuo Kitamura
    Hypertension Research, 2011, 34 : 331 - 335
12345